Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...

The move comes after M23 seized the Congolese city of Uvira, just weeks after a peace deal brokered by President Trump. New York City paid $117 million last year to settle 1,044 lawsuits alleging ...